CVS Health Corporation CVS

89.13 4.08 4.80% as of 25 Sep
Market cap
$108.5B
P/E
23.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

CVS Health Corporation (CVS) EV/EBITDA

As of 25 September 2026, CVS Health Corporation (CVS) trades at a EV/EBITDA of 8.7×. Over the past ten years it has ranged from 6.7× (December 2018) to 15.5× (December 2022); the current reading is higher than 37% of that period. That is below the Healthcare Plans industry median of 10.9× and below the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 10.3× 20.90%
FY2024 8.5× 0.22%
FY2023 8.5× (34.61%)
FY2022 13.0× 31.94%
FY2021 9.9× 26.36%
FY2020 7.8× (18.74%)
FY2019 9.6× (8.50%)
FY2018 10.5× 27.77%
FY2017 8.2× (4.22%)
FY2016 8.6× (26.10%)

Quarterly

Period EV/EBITDA Change
Jun 2026 9.7× 10.47%
Mar 2026 8.8× (14.83%)
Dec 2025 10.3× 4.58%
Sep 2025 9.9× (4.10%)
42 more quarters

Against its own ten years

Low 6.7× High 15.5×
Ten-year median 9.3×
Current reading's percentile 37

EV/EBITDA against peers

Company EV/EBITDA
CLOV Clover Health Investments, Corp. compare n/m
CNC Centene Corporation compare n/m
CI Cigna Group compare 7.7×
OSCR Oscar Health, Inc. compare 8.4×
CVS CVS Health Corporation 8.7×
ELV Elevance Health, Inc. compare 9.0×
HUM Humana Inc. compare 10.9×
MOH Molina Healthcare, Inc compare 13.0×
UNH UnitedHealth Group Incorporated compare 14.5×
Healthcare Plans industry median 10.9×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CVS